DEXUS (DXS) Stock Price, News & Analysis

Company Overview

Dexus (ASX: DXS) is a leading Australasian fully integrated real asset group, managing a high-quality Australasian real estate and infrastructure portfolio valued at $61.0 billion (pro forma post final completion of the AMP Capital acquisition). We believe that the strength and quality of our relationships will always be central to our success and are deeply connected to our purpose: Unlock potential, create tomorrow. We directly and indirectly own $17.4 billion of office, industrial, healthcare, retail and infrastructure assets and investments. We manage a further $43.6 billion of investments in our funds management business (pro forma post final completion of the AMP Capital acquisition) which provides third party capital with exposure to quality sector specific and diversified real asset products. The funds within this business have a strong track record of delivering performance and benefit from Dexus's capabilities. The group's $17.4 billion real estate development pipeline provides the opportunity to grow both portfolios and enhance future returns. Our sustainability aspiration is to unlock the potential of real assets to create lasting positive impact and a more sustainable tomorrow, and is focused on the priorities of customer prosperity, climate action and enhancing communities. Dexus is supported by more than 34,000 investors from 25 countries. With four decades of expertise in property investment, funds management, asset management and development, we have a proven track record in capital and risk management and delivering returns for investors.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 5.01 million shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 6.31%
• Price Target: N/A
• Consensus Rating: N/A

DXS Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of DEXUS own?

Based on aggregate information from My MarketBeat watchlists, some other companies that DEXUS investors own include Medibank Private (MPL), Accenture (ACN), AECOM (ACM), Accel Entertainment (ACEL), Abbott Laboratories (ABT), Abacus Property Group (ABP) and AbbVie (ABBV).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Real Estate
• Industry: REIT - Office
• Sub-Industry: N/A
• Current Symbol: ASX:DXS
• CUSIP: N/A
• CIK: N/A
• Web: www.dexus.com
• Phone: +61-2-90171100
• Fax: N/A
• Employees: 1,079
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A($1.47)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 3.87
• Net Income: $-1,580,000,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -14.12%
• Return on Assets: -0.80%

Debt

• Debt-to-Equity Ratio: 49.54
• Current Ratio: 0.95
• Quick Ratio: 0.44

Sales & Book Value

• Annual Sales: $338.30 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 175.29
• Book Value: A$9.48 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,080,000,000
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 0.81